Summary
The level of expression of genes encoding for nine major xenobiotic metabolising Cytochrome P450s (CYPs) and the P-glycoprotein (Pgp) was determined in three different regions of the small intestine of male and female Sprague Dawley rats and the expression was compared with that in the liver. A semi-quantitative RT-PCR method, using the total RNA from the tissues, was established for the determination of the level of gene expression.
Four of the CYP genes: the CYP2B1, CYP2C6, CYP2C11 and CYP2D1 and the Pgp were expressed at as high levels in the small intestine as in the liver. The expression of the other CYP genes was remarkably different in the two organs. The CYP1A2, CYP2A3, CYP2E1 and CYP3A1 showed a strong expression in the liver but only a comparatively weak or no expression in the small intestine. The CYP1A1 on the other hand exhibited a stronger expression in the small intestine than in the liver.
With the exception of the CYP2A3, none of the genes showed a clear regional distribution in their small intestinal expression. Furthermore, no obvious sex difference in the expression of the CYP and Pgp genes could be observed.
Our results indicate that several of the enzymes, central for drug metabolism are differently expressed in the liver and in the small intestine of the rat which should be taken into account when using rat as a model for the bioavailability and organ specific toxicity studies of orally administered xenobiotics. The apparently strong small intestinal expression of the CYP2C genes suggests that these enzymes could play a key role in the intestinal drug metabolism in rats and therefore affect the bioavailability of those orally used drugs which are substrates of the CYP2Cs. This possibility should be investigated in more detail both in rats and humans.
Similar content being viewed by others
References
Porter T.D. and Coon M.J. (1991): Cytochrome P-450. J. Biol. Chem., 266, 13469–13472
Borst P., Schinkel A.H., Smit J.J.M., Wagenaar E., van Deemter L., Smith A.J., Eijdems E.W.H.M., Baas F. and Zaman G.J.R., (1993) Classical and Novel Forms of Multidrug Resistance and the Physiological Functions of P-glycoproteins in Mammals. Pharmac. Ther., 60, 289–299)
Salphati L. and Benet L.Z., (1998): Modulation of P-glycoprotein Expression by Cytochrome P450 3A Inducers in Male and Female Rat Liver. Biochem. Pharmacol., 55, 387–395
Wacher V.J., Silverman J.A., Zhang Y., Benet L.Z., (1998): Role of P-glycoprotein and Cytochrome P450 3A in Limiting Oral Absorption of Peptides and Peptidomimetics J. Pharm. Sci., 87, 1322–1330
Nelson D.R., Kamataki T., Wexman D.J., Guengerich F.P., Estabrook R.W., Feyereisen R., Gonzalez F.J., Coon M.J., Gunsalus I.C., Gotoh O., Okuda K., and Nebert D.W., (1993): The P450 Superfamily: Update on New Sequences, Gene Mapping, Accession Numbers, Early Trivial Names of Enzymes, and Nomenclature. DNA and Cell Biol., 12, 1–51
Paine M.F., Shen D.D., Kunze K.L., Perkins J.D., Marsh C.L., McVicar J.P., Barr D.M., Gillies B.S. and Thummel K.E., (1996): First-pass Metabolism of Midazolam by the Human Intestine. Clin. Pharmacol. There., 60, 14–24
Wu C-Y., Benet L.Z., Hebert M.F., Gupta S.K., Rowland M., Gomez D.Y. and Wacher V.J., (1995): Differentiation of Absorption and Firstpass Gut and Hepatic Metabolism in Humans: Studies with Cyclosporine. Clin. Pharmacol. Ther., 58, 492–497
Reg_rdh C.G., Edgar B., Olsson R., Kendall M., Collste P and Shansky C., (1989): Pharmacokinetics of Felodipine in Patients with Liver Disease. Eur. J. Clin. Pharmacol., 36, 473–479
Fromm M.F., Busse D., Kroemer H.K., and Eichelbaum M. (1996): Differential Induction of Prehepatic and Hepatic Metabolism of Verapamil by Rifampin. Hepatology. 24, 796–801
Bai J.P.F. (1994): Distribution of Brush-Border Membrane Peptidases Along the Rat Intestine. Pharmaceutical Research, 11, 897–900
Traber P.G., McDonnell W.M., Wang W. and Florence R. (1992): Expression and Regulation of Cytochrome P-450I Genes (CYP1A1 and CYP1A2) in the Rat Alimentary Tract. Biochimicia et Biophysica Acta., 1171, 167–175
Zhang Q-Y., Wikoff J., Dunbar D. and Kaminsky L. (1996): Characterization of Rat Small Intestinal Cytochrome P450 Composition and Inducibility. Drug Metab. Dispos., 24, 322–328
De Waziers I., Cugnenc P.H., Yang C.S., Leroux J-P., and Beaune P.H. (1990): Cytochrome P 450 Isoenzymes, Epoxide Hydrolase and Glutathione Transferases in Rat and Human Hepatic and Extrahepatic. Tissues J. Pharmacol. Exp. Ther., 253, 387–394
Kaminsky L.S. and Fasco M.J. (1991): Small Intestinal Cytochromes P450. Crit. Rev. Toxicol., 21, 407–422
Zhang J. and Ding X. (1998): Identification and Characterization of a Novel Tissue-specific Transcriptional Activating Element in the 5_-Flanking Region of the CYP2A3 Gene Predominantly Expressed in Rat Olfactory Mucosa. J. Biol. Chem., 273, 23454–23462
Gonzalez F.J. (1989): The Molecular Biology of Cytochrome P450s. Pharmacological Reviews, 40, 243–288
Honkakoski P., Mäenpää J., Leikola J., Pasanen M., Juvonen R., Lang M.A. Melkonen O., and Raunio H. (1993): Cytochrome P4502A-Mediated Counmarin 7-Hydroxylation and Testosterone Hydroxylation in Mouse and Rat Lung. Pharmacol. & Toxicol., 72, 107–112
Béréziat J-C., Raffalli F., Schmezer P., Frei E., Geneste O. and Lang M.A. (1995): Cytochrome P450 2A of Nasal Epithelium: Regulation and Role in Carcinogen Metabolism. Mol. Carcinogenesis, 14, 130–139
Godoy W., Albano R.M., Moraes E.G., Alves Pinho P.R., Nunes R.A., Saito E.H., Higa C., Filho I.M., Pinto Kruel C.D., Schirmer C.C., Gurski R., Lang M.A., and Ribeiro Pinto L.F. (2002): CYP2A6/2A7 and CYP2E1 Expression in Human Oesophageal Mucosa: Regional anf Inter-individual Variation in Expression and Relevance to Nitrosamine Metabolism. Carcinogenesis, 23, 611–616.
Iber H., Chen Q., Sewer M., and Morgan E.T. (1997): Regulation of Hepatic Cytochrome P450 2C11 by Glucocorticoids. Arch. Biochem. Biophys., 345, 305–310
Hiroi T., Imaoka S., Chow T. and Funae Y. (1998): Tissue Distribution of CYP2D1, 2D2, 2D3 and 2D4 mRNA in Rats Detected by RT-PCR. Biochimica et Biophysica Acta, 1380, 305–312
Hakkak R., Korourian S., Ronis M.J.J., Ingelman-Sundberg M. and Badger T.M. (1996): Effects of Diet and Ethanol on the Expression and Localization of Cytochromes P450 2E1 and P450 2C7 in the Colon of Male Rats. Biochem. Pharmacol., 51, 61–69
Shimizu M., Lasker J.M., Tsutsumi M. and Lieber C.S. (1990): Immunohistochemical Localization of Ethanol-Inducible P450IIE1 in the Rat Alimentary Tract. Gastroenterology, 99, 1044–1053
Kocarek T.A., Zangar R.C. and Novak R.F. (2000): Post-transcriptional Regulation of Rat CYP2E1 Expression: Role of CYP2E1 mRNA Untranslated Regions in Control of Translational Efficiency and Message Stability. Arch. Biochem. Biophys., 376, 180–190
Kolars J.C., Schmiedlin-Ren P., Dobbins III W.O., Schuetz J., Wrighton S.A., and Watkins, P.B. (1992): Heterogeneity of Cytochrome P450IIIA Expression in Rat Gut Epithelia. Gastroenterology, 102, 1186–1198
Johnson T.N., Tanner M.S., and Tucker G.T., (2000): A Comparison of the Ontogeny of Enterocytic and Hepatic Cytochromes P450 3A in the Rat. Biochem. Pharmacol., 60, 1601–1610.
Makhey V.D., Guo A., Norris D.A., Hu P., Yan J. and Sinko P.J. (1998) Characterization of the Regional Intestinal Kinetics of Drug Efflux in Rat and Human Intestine and in Caco-2 Cells. Pharmaceutical Research, 15, 1160–1167
Mugford C.A., and Kedderis G.L. (1998): Sex-dependent Metabolism of Xenobiotics. Drug. Metabolism Reviews 30, 441–498
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Lindell, M., Lang, M. & Lennernäs, H. Expression of genes encoding for drug metabolising cytochrome P450 enzymes and P-glycoprotein in the rat small intestine; comparison to the liver. Eur. J. Drug Metab. Pharmacokinet. 28, 41–48 (2003). https://doi.org/10.1007/BF03190865
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF03190865